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Abstract
Background There are fetuses demonstrating very large
myelomeningocele lesion which can not be covered with
autochothonous skin.
Material and Methods We use IntegraTM artifical skin for
intrauterine coverage of the back lesion. A reverse latissi-
mus dorsi flap was used postnataly to reinforce the repair
site.
Conclusion IntegraTM appears to be a suitable coverage
for large soft tissue defects in utero. Moreover, a postnatal
reverse latissimus dorsi flap appears to markedly strengthen
tissue coverage over a spinal cord rescued in utero.
Keywords Fetal surgery  In utero repair 
Myelomeningocele  Spina bifida  Integra artificial
skin  Latissimus dorsi flap
Introduction
In the early 1990’s, a fundamentally new way of under-
standing the pathogenesis of myelomeningocele (MMC)
was introduced. The newly developed ‘‘two-hit-hypothesis’’
proposed that the postnatal MMC lesion was the combined
product of early gestational failure of neurulation (‘‘first
hit’’) and subsequent progressive destruction of the open
unprotected spinal cord tissue during the remainder of
gestation (‘‘second hit’’) [4, 6]. This novel view lead to the
assumption that early in utero intervention might stop the
otherwise ongoing neural tissue destruction and so signifi-
cantly reduce the neurologic deficit seen at birth.
In fact, a sizeable experimental [7, 16] as well as pre-
liminary clinical [1, 3, 6, 18] body of evidence gathered
over the past 2 decades has indicated that in utero repair of
MMC may significantly improve neurologic outcome. The
very best data supporting in utero repair as a new standard
of care for selected fetuses with MMC was produced by the
Management of Myelomeningocele Study (MOMS), a
prospective randomized trial recently published in a mile-
stone article in the New England Journal of Medicine [2].
As a direct consequence of the quoted evidence, we
have opened a fetal surgery program at our center in close
cooperation with The Center for Fetal Diagnosis and
Treatment of the Department of Surgery of the Children’s
Hospital of Philadelphia. So far, nine maternal–fetal sur-
geries for MMC have been performed [9].
Obviously, there are numerous substantial operative
challenges the fetal surgeon faces during these highly
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demanding interventions. The last step of the fetal opera-
tion is skin closure over the repair site that may prove
particularly difficult or even not feasible, especially when
the skin defect is large and when there is marked tissue
frailty as in earlier gestational fetuses. The goal of this
article is to detail our initial experience using IntegraTM
(Integra LifeScience, Plainsboro, NJ, USA) to close an
extensive skin defect during open fetal MMC repair.
Case report
Diagnostic workup and prenatal counseling
A healthy 25-year-old G1P1 female was diagnosed with a
male fetus demonstrating a spina bifida in the 21st week of
gestation. On ultrasound, the fetus had a large, wide open
lumbosacral spina bifida with the exposed neural placode
resting at the bottom of the open spinal canal (Fig. 1). Thus,
the diagnosis of a lumbosacral myeloschisis with a cranial
level of lumbar 4–5 was made. Moreover, the fetus exhib-
ited the typical Chiari II malformation and a mild ventri-
culomegaly (10 mm). Lower extremity movements at hip,
knee, ankle, and toe levels were normal bilaterally. The
urinary bladder demonstrated normal cycling and the fluid
filled stomach was well discernable. No other malforma-
tions were found. The preoperative fetal MRI confirmed
these findings and did not reveal any other pathology.
Both mother and fetus met all other inclusion criteria for
fetal surgery set forth by the MOMS-Trial and they did not
fulfill any of the exclusion criteria [2]. Both parents
underwent extensive multidisciplinary non-directive coun-
seling. All known risks and potential benefits associated
with maternal–fetal surgery were explicitly discussed. In
addition, all problems and handicaps presumably present,
when standard postnatal care would be chosen, were
explained in detail. Parents were given sufficient time to
decide and were also told that they could change their
decision at any time. The parents opted for fetal surgery
and a written informed consent was obtained.
Maternal–fetal surgery
Maternal–fetal surgery was performed at 22 3/7 weeks of
gestation according to the protocol used for the MOMS-
Trial [2]. A generous transverse lower abdominal laparot-
omy was performed and the uterus was partly exteriorized.
Because of an anterior wall placenta, the uterus was opened
on the posterior wall. Subsequently, the fetus was posi-
tioned by gentle manipulation so that the lesion was well
exposed. We found a large (2.8 9 1.8 cm) myeloschisis
with the open dura mater merging circumferentially into the
normal-looking surrounding skin (Fig. 2). The dura was
then dissected free, the dura flaps were flipped over and
sutured together over the spinal cord after the filum termi-
nale had been severed in order to attain the obligatory un-
tethering. Because of the very large and mainly sacral
lesion, we could not prepare adequately sized paraspinal
myofascial flaps, and also, it was definitely impossible to
achieve primary skin closure over the defect. Therefore, we
decided to implant a piece of IntegraTM. The product was
shaped to suit the defect, placed over the defect, and sewn to
the surrounding skin edges with a running suture (PDS 4.0,
RB-1, Ethicon, Johnson & Johnson, Norderstedt, Germany)
(Fig. 3). After returning the fetus deep into the amniotic
cavity, the amniotic fluid was restored to an appropriate
volume with lactated Ringers solution by continuous infu-
sion during uterine closure. The uterus was closed using an
Fig. 1 Cross section through the lesion at level L5/S1. The open
spine is clearly visible and so is the spinal cord tissue that rests at the
bottom of the spinal canal. The absence of a cystic sac makes this
lesion a classical myeloschisis
Fig. 2 Overview of the fetal lesion just prior to commencing repair.
The open dura mater is shiny and merges into the intact skin (arrows)
that surrounds the lesion. The non-neurulated spinal cord is macro-
scopically intact (within dotted line)
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inner running suture and multiple interrupted outer sutures,
and the suture line was sealed with an omental flap. The
maternal laparotomy was closed in layers.
Continuation of pregnancy, post-interventional fetal
MRIs, and Cesarean section
At 4 and 8 weeks after the prenatal intervention, fetal MRIs
were obtained demonstrating complete reversal of hind-
brain herniation, a growing posterior fossa, absence of
significant ventriculomegaly, an unremarkable repair site,
and good leg function. The IntegraTM patch could not be
identified as such with a high level of confidence.
Pregnancy continued uneventfully with a mild tocolytic
regimen until week 37 0/7 at which time point the fetus was
electively delivered by Cesarean section. The mother had
an uncomplicated postoperative course and was discharged
from the hospital on postoperative day 5.
Management of the newborn baby
The baby boy (head circumference 34 cm [P: 25–50],
weight 3,090 g [P: 50], length 46.5 cm [P: 3–10]) adapted
normally (Apgar 7/9/9), demonstrated vigorous bilateral leg
movements with clearly present extension and flexion pat-
terns at all joint levels, and had a normally configured anus.
The repair site was solidly healed with a well vascularised,
non-epithelialized, and apparently watertight membrane at
the former IntegraTM implantation site (Fig. 4). This ‘‘neo-
dermis’’, measuring 5 9 4 cm, was firmly attached to the
skin and there was no leak of cerebrospinal fluid detectable.
When the baby cried we could observe a slight outward
bulging of the membrane. The surface of the neodermis was
macroscopically clean, there was no inflammatory reaction
nor were there visible traces of vernix caseosa or meconium.
The upper silicone layer of the originally bilayered product
was found sticking to the left inguinal area.
Because of the obviously very thin tissue coverage over
the spinal cord, we decided to further strengthen the cord
protection with additional tissue. Therefore, the left-sided
latissimus dorsi muscle was conceived as a distally based
pedicled flap, detached from the humeral base, and pre-
pared free down to the iliac crest area, where 3 sizeable sets
of perforator vessels were identified to perfuse the entire
flap. The muscle was then turned over, swung over the
lesion, and fixed to the adjacent tissue with single stitches
(Fig. 5). The most distal part of the defect was closed
primarily after undermining the surrounding soft tissue.
The clinically well perfused muscle surface was covered
with 0.1-mm-thick non-meshed split skin harvested from
the adjacent left gluteal area.
The patient was placed in a prone position for 3 weeks
and his postoperative course was uneventful with healing
of the muscle flap and skin graft (Fig. 6a). During this time,
the baby repeatedly had normal neurologic examinations
except for a slightly diminished plantar flexion of the right
foot, normal head growth (P: 10–25), and normal voiding
functions. Bladder manometry was normal. A baseline
MRI, performed on day 20 of life, corroborated the find-
ings from the two post-interventional fetal MRIs and also
demonstrated a robust and viable muscle flap covering the
Fig. 3 A patch of IntegraTM is being implanted into the skin defect
and fixed with a running suture. The shiny surface is the upper layer
consisting of silicon (the lower layer is dull and consists of
extracellular matrix material, not visible)
Fig. 4 This picture shows the repair site immediately after birth. The
former back lesion is covered with a thin, well vascularized, but non-
epithelialized connective tissue membrane (neodermis,
ND5 9 4 cm). There are no signs of inflammation nor is there a
CSF leak detectable. We have put the silicon membrane (SM) that
was found in the left inguinal area adjacent to the repair site
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lesion (Fig. 6b). The patient was discharged home on his
second day of life. At last follow-up (3 months of age), the
patient was doing well with stable neurologic exam and
normal bladder manometry.
Discussion
We report the successful implantation of IntegraTM during
fetal surgery as primary skin coverage in the context of a
very large MMC defect (deeper layers closed with
autochthonous tissues). Furthermore, this is also the first
report on the use of an immediate postnatal reverse la-
tissimus dorsi flap to provide additional soft tissue cover-
age for a prenatally salvaged spinal cord.
Basically, we used the same simple technique for the
IntegraTM implantation used for postnatal application [14].
A custom tailored piece of IntegraTM was circumferentially
sewn to surrounding fetal skin using a running suture so as
to completely cover the residual skin defect after MMC
repair was completed. Before returning the fetus back to
his natural amniotic fluid environment, there was a solid
contact of the lower IntegraTM layer, i.e., the extracellular
matrix (=dermal template), with the wound bed, and the
suture line appeared tight and waterproof. It is reasonable
to assume that IntegraTM showed a similar biological
behavior as seen when used postnatally. Likely, the
extracellular matrix was rapidly populated by cells
migrating from the wound bed, especially fibroblasts and
vascular endothelial cells. These two cell types are seen as
key players orchestrating the transition from the acellular
dermal template, consisting of an array of typically arran-
ged extracellular matrix molecules, to a viable, visibly
vascularised, and functionally competent connective tissue
membrane, as present at birth [14, 17, 19].
When used postnatally, the dermal template is usually
well vascularised and solidly integrated into the wound bed
3–4 weeks post implantation [13–15, 17]. At that time
point, the upper silicon layer is peeled off and the neo-
dermis is covered with a very thin split thickness skin graft
so as to complete skin reconstruction.
In this case, IntegraTM was hidden from view for about
4 months, and the silicone membrane was detached at
birth. This is not surprising since the silicon layer tends to
spontaneously detach after 4–6 weeks when used in the
postnatal setting. We speculate that the silicon sheet was
gradually disengaged during gestation as the maturing
neodermis grew into an autonomous and compact structure.
Experimentally, IntegraTM was successfully used in
conjunction with a cellulose sheet to cover skin defects in
fetal sheep [12]. Moreover, we have a favorable, long-
standing and extensive clinical experience using this
product in burns [17], scar revisions [17], avulsion injuries
[13], and naevus surgery [14] in children. Nevertheless, the
following potential problems, specific to the fetal setting,
might have jeopardized success. First, the continued pre-
sence of amniotic fluid might have led to fluid collection
beneath the product with failed integration of the dermal
template into the wound. Second, in contrast to postnatal
Fig. 5 The left-sided, distally pedicled and well perfused latissimus
dorsi flap (LDF) was turned over and is now being sutured to the
wound edges
Fig. 6 a Perfectly healed repair site (arrow) 3 weeks after perform-
ing the reverse latissimus dorsi coverage and split thickness skin
grafting. LDDS latissimus dorsi donor site, dotted line split skin donor
site. b Postnatal MRI obtained 3 weeks post birth. Asterisk spinal
cord, CSF cerebrospinal fluid, LDF latissimus dorsi muscle flap
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application, there was no dressing over the IntegraTM
assuring tight contact with the wound bed with again the
risk of failed integration. Finally, after the protective sili-
con sheet was detached, the freshly grown and, therefore,
fragile connective tissue membrane might have been
damaged traumatically (rubbing against and bumping into
uterine wall) or biochemically (enzymes and toxic mole-
cules increasingly present in the amniotic fluid towards the
end of gestation). Even though we did not see any of these
problems, it takes more cases to quantify these risk factors.
The literature does not provide formal publications on
coverage alternatives when there is a big residual skin
defect. Yet, Mazzola et al. mention that AlloDerm pat-
ches (LifeCellTM, Bridgewater, NJ, USA) have been used
as skin substitutes during fetal surgery followed by skin
flaps performed neonatally [5].
The postnatal back wound management deserves a
comment. Clearly, the repair site was in need of a definitive
skin coverage that could have been easily realized with a
split thickness skin graft. Given the obvious tissue thinness
covering the neural tissue that was almost visible through the
neodermis, and the consequent vulnerability of the spinal
cord, we decided to additionally shield this locus minoris
resistentiae with a distally pedicled, reverse latissimus dorsi
flap. This technique has been used by ourselves and others
postnatally to provide adequate soft tissue coverage over
very large MMC defects [20]. In addition, we reported on
successfully using latissimus dorsi flaps for in utero repair of
experimental MMC in fetal sheep [7, 8, 11]. And finally, we
published a feasibility study in aborted human fetuses of
different gestational ages showing that almost the entire
spine can be reached with proximally or distally pedicled
latissimus dorsi flaps [10]. There is no literature on using the
latissimus dorsi flap in neonates with a history of fetal sur-
gery. Yet, both our clinical and postnatal MRI findings
(Fig. 6a, b) indicate that this maneuver markedly reinforces
the vitally important spinal cord and should be considered in
similar situations. There is no study looking at the functional
long-term outcome after neonatal use of latissimus dorsi
flaps. The only information available comes from three of
our own patients with MMC who underwent latissimus dorsi
flap plasties (2 9 monolateral, 1 9 bilateral) as neonates (on
days 2, 3, and 5 of life). Their shoulder function was recently
analyzed in detail at ages 6, 11, and 16 years, respectively.
There was no significant functional deficit with regard to
shoulder/arm function (Osinga, unpublished data).
In summary and conclusion, this appears to be the first
report on the successful use of IntegraTM as a skin sub-
stitute during open human fetal surgery for MMC, and it
also appears to be the first report on the use of the latiss-
imus dorsi muscle to maximally strengthen soft tissue
coverage over a prenatally rescued spinal cord immediately
after birth.
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